AOL Money & Finance

RAD posts

Feed

Earnings highlights: AutoZone, Carnival, CarMax, ConAgra, General Mills, RIM ...

Here are some highlights from last week's earnings coverage from BloggingStocks:

Continue reading Earnings highlights: AutoZone, Carnival, CarMax, ConAgra, General Mills, RIM ...

Rite Aid plunges after slashing full-year outlook

Rite Aid Corp. (NYSE: RAD) wallowed in the red Thursday morning, after the drugstore chain disappointed Wall Street with its second-quarter earnings and full-year guidance.

Rite Aid said its quarterly loss narrowed to $116 million, or 14 cents per share, while revenue dwindled 2.7% to $6.3 billion. Same-store sales dipped 1.1%, while gross margin contracted from 27.4% to 26.7%.

Continue reading Rite Aid plunges after slashing full-year outlook

The week in preview: Eye on AutoZone, ConAgra, KB Home, Research In Motion ...

Much of the focus this week will no doubt be on the FOMC meeting on interest rates and the subsequent decision, as well as on the G-20 meeting in Pittsburgh, were the agenda will include bonuses for bank executives among other things.

Things will be fairly quiet again on the earnings front as the next earnings season has yet to ramp up. However, analysts surveyed by Thomson Reuters do have high hopes for a handful of companies that will release results this week.

Continue reading The week in preview: Eye on AutoZone, ConAgra, KB Home, Research In Motion ...

Closing Bell: Kicking off Q3 with a win (AIG, BIIB, LDK, PIR, RAD)

Stocks opened up on the day and stayed up on the day, despite closing well off of the highs. We had three key economic reports hit at once as the Institute for Supply Management gave the June ISM Manufacturing data, while we saw pending home sales data and new construction spending data mixed for May. These actually ended up being contradictory numbers, and then the oil inventories did nothing to support higher oil prices.

Here were today's unofficial closing bell levels:

Dow 8,504.06 +57.06 (0.68%)
S&P 500 923.33 +4.01 (0.44%)
Nasdaq 1,845.72 +10.68 (0.58%)

Top Analyst Upgrades & Downgrades

Continue reading Closing Bell: Kicking off Q3 with a win (AIG, BIIB, LDK, PIR, RAD)

Earnings highlights: Nike, Oracle, Kroger, Walgreen, Monsanto, KB Home ...

Here are some highlights from this past week's earnings coverage from BloggingStocks:

Continue reading Earnings highlights: Nike, Oracle, Kroger, Walgreen, Monsanto, KB Home ...

Rite Aid beats analysts, but not right for me yet

Rite Aid (NYSE: RAD), which competes with Walgreen (NYSE: WAG), CVS Caremark (NYSE: CVS), and Wal-Mart (NYSE: WMT), saw a big increase in volume on Wednesday after it reported earnings for the first quarter. In fact, as Douglas McIntyre observed, shares of Rite Aid were up 5% at one point during yesterday's session. However, the shares ended up losing their green status by the close of trading. Rite Aid actually lost 3% when all was said and done. What does it all mean?

Well, Rite Aid did beat analyst forecasts by a wide margin. The call was for a loss of 13 cents per share. Rite Aid lost only 6 cents per share once adjustments are made. Revenues dipped a little over 1%, and same-store sales, after excluding the effect of the Brooks Eckerd acquisition, increased 1.5%. Interestingly, the mix of this increase is as follows: the pharmacy sales went up 3.1% on a comparable basis, and the non-pharmacy sales went down 1.4% on the same basis.

Continue reading Rite Aid beats analysts, but not right for me yet

Today's big stock price moves on big volume

Today was an unusually active day for extremely volume increases in several stocks which traded on news and rumors.

Shares in Sequenom (NASDAQ: SQNM) jumped over 10% on takevover rumors.

Rite Aide (NYSE: RAD) moved higher by 5% on larger than normal volume as it beat earnings estimates and Monsanto (NYSE: MON) traded up on strong numbers and took a number of agriculture stocks with it. Oracle (NASDAQ: ORCL) also benefited from earnings above Wall Street forecasts.

Palm (NASDAQ: PALM) traded higher as RBC upped its price target to $18 from $14, and MEMC (NYSE: WFR) fell on a downgrade from JPMorgan.

Douglas A. McIntyre is an editor at VSInvestor.com.

The week in preview: End-of-quarter earnings expectations: Nike, Oracle, Walgreen ...

This week brings a small flurry of end-of-the-calendar-quarter earnings reports. And for the most part, the expectations of the analysts surveyed by Thomson Reuters aren't very high. Companies expected to report declining earnings in the most recently concluded quarter include America's Car-Mart Inc. (NASDAQ: CRMT), Bed Bath & Beyond Inc. (NASDAQ: BBBY), ConAgra Foods Inc. (NYSE: CAG), Jabil Circuit Inc. (NYSE: JBL), Jackson Hewitt Tax Service Inc. (NYSE: JTX), Monsanto Co. (NYSE: MON), and Sonic Corp. (NASDAQ: SONC).

Continue reading The week in preview: End-of-quarter earnings expectations: Nike, Oracle, Walgreen ...

Walgreen to report Q3 numbers: What should we look for?

Walgreen (NYSE: WAG), a drugstore business that competes with CVS Caremark (NYSE: CVS) and Rite-Aid (NYSE: RAD), will be issuing results for the third quarter on Monday, June 22. According to Earnings.com, the analyst community is prescribing $0.56 per share for the company.

Of course, the question is: will Walgreen honor that prescription and fill it? I'd say it's quite possible. Last time around, Walgreen beat estimates. The call was for $0.66 per share in Q2. If you look at the press release from that time, you'll see that, once you adjust for some items, Walgreen went beyond expectations.

Continue reading Walgreen to report Q3 numbers: What should we look for?

Earnings highlights: Research in Motion, Monsanto, Apollo Group, Borders and more

Here are some highlights from this past week's earnings coverage from BloggingStocks:

Continue reading Earnings highlights: Research in Motion, Monsanto, Apollo Group, Borders and more

Rite Aid up on Q4 report -- can you buy it now?

Rite Aid (NYSE: RAD), whose competitors include Walgreen (NYSE: WAG), CVS Caremark (NYSE: CVS), and Wal-Mart (NYSE: WMT), reported Q4 numbers today, and when you read through the release, you sort of come away with a decent feeling. You hear about improvements in this metric and that metric. You wonder if a turnaround might be in the offing. Then you look at the stock price and, even though it is currently being bid higher (it's up over 14% as I write), you come back down to earth and reality hits you in the face. Anything trading under a buck has to give you pause. Rite Aid is no different.

For the quarter, Rite Aid posted a 1.7% decrease in the top line. On an adjusted basis, the drugstore chain reported a loss of $0.14 per share. According to this source, Wall Street thought Rite Aid might lose $0.105 per share. The company is still adjusting to the Brooks Eckerd acquisition. Excluding that effect, same-store sales increased 0.8%. Including the asset, comps decreased 0.1%.

Continue reading Rite Aid up on Q4 report -- can you buy it now?

Walgreen looking for growth with wellness network

Walgreen (NYSE: WAG ) knows that people want all kinds of options to meet their healthcare needs. Walgreen also knows that it needs to grow and keep up with competitor CVS Caremark (NYSE: CVS) and the pharmacy department at Wal-Mart (NYSE: WMT). And, yes, I suppose Rite-Aid (NYSE: RAD) is technically a competitor, too, although you wouldn't know it by that drugstore chain's stock price. Well, according to The Wall Street Journal, Walgreen plans to promote an initiative called "Complete Care and Well-Being" to employers. The goal here is to give corporate, as well as government, employees and their families access to healthcare services such as preventive medicine and dental examinations in off-hour time periods. Walgreen will use a network of in-store clinics and health centers to provide these services. That's pretty cool, right? Well, one of the bigger benefits to Walgreen is the synergy it can promote by leveraging this program.

Continue reading Walgreen looking for growth with wellness network

Stock picks and pans for troubled times: ATVI, MCD, WMT, WSM, AMGN, AEO ...

The first trading session of the 2009 may have brought some optimism with it as markets rallied, but it's difficult to imagine all our troubles over after a year that set one bad and worse record after another. Stocks mirrored the global economic slowdown brought on by the housing market and the financial markets crises.

Still, there are many who still seek to invest in hope that one day they could get nice returns on their investments. While the recent volatility in the stock market benefited some shrewd day traders, most investors know to stick to a long-term, stable investment plan.

To help achieve some of these long-term return, BloggingStocks contributors continued to suggest some companies to invest in, as well as some to avoid:

Activision Blizzard (NASDAQ: ATVI) -- despite having his confidence in the stock shaken somewhat lately as sales may have been softer than expected, Steven Mallas is still bullish on the stock and feels it is attractive at these levels. Take-Two Interactive (NASDAQ: TTWO), however, "seems a little scary to be buying in now," he says.

Continue reading Stock picks and pans for troubled times: ATVI, MCD, WMT, WSM, AMGN, AEO ...

Could 25% of American retailers fail? (RAD) (PIR)

It seems so astonishing that it can't be true, but there are experts who believe that 25% of American retailers could fail over the course of the next year or two. According to The Wall Street Journal (subscription required), "AlixPartners LLP, a Michigan-based turnaround consulting firm, estimates that 25.8% of 182 large retailers it tracks are at significant risk of filing for bankruptcy or facing financial distress in 2009 or 2010."

If an extremely large number of retailers do close, the job loss could be incredible. Troubled retailer Pier 1 (NYSE: PIR), which trades at $0.33, has more than 6,100 employees. Rite Aid (NYSE: RAD), which also trades at $0.33, has over 60,000. If several medium-sized to large store chains move into bankruptcy, hundreds of thousands of jobs will be at stake. This does not include more modest-sized operators.

The retail industry is critical to the American economy. If it falls apart rapidly, it helps put the recession into a deeper downward spiral. Retail employees lose jobs and then are no longer consumers. With fewer consumers, more retailers and other business fail. Tax income for municipal, state, and the federal governments is also undermined, putting pressure on government employment.

The jobless rate my be close to 7% now. The retail part of the economy could move that number up quite a bit all by itself.

Douglas A. McIntyre is an editor at 247wallst.com.

Earnings preview: Will Walgreen's Q1 be healthy or ailing?

Walgreen (NYSE: WAG), a major drugstore chain whose enemies include CVS Caremark (NYSE: CVS) and Rite-Aid (NYSE: RAD), is getting ready to report earnings for its first fiscal quarter on Monday, December 22. It's Christmas week. Will Walgreen bestow a gift of an earnings beat upon the market?

One thing's for sure: the market does not expect much from the drugstore. Wall Street expects flat performance in Q1. The bottom line should come in somewhere around $0.46 per share, the exact same amount that was booked last year. You know, you figure the company should be able to at least match expectations when the bar is set so low. But it might be tough. We all need access to prescriptions and over-the-counter medications every now and then, and on top of that, many people obviously require long-term drug regimens. So, we can see that the pharmacy part of the equation is somewhat resistant to recession. However, there isn't a pressing need for all the non-pharmacy items in a Walgreen location. You don't need to buy any of those cheap plastic toys, any of those blenders that don't work too well, any of the overpriced groceries, etc. This is where Walgreen has exposure to the weakening consumer. Indeed, the consumer is becoming more and more of a value Grinch as time goes on. People just don't want to pay any more than they have to.

Continue reading Earnings preview: Will Walgreen's Q1 be healthy or ailing?

Next Page >

Symbol Lookup
IndexesChangePrice
DJIA+17.4610,023.42
NASDAQ+7.122,112.44
S&P 500+2.671,069.30

Last updated: November 08, 2009: 09:59 PM

BloggingStocks Exclusives

Hot Stocks

DailyFinance Headlines

Latest from BloggingBuyouts

WalletPop Headlines

AOL Business News

BioHealth Investor Headlines

Sponsored Links

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

BloggingStocks Partners

More from AOL Money & Finance